Officer/Director Transaction: Rosengarten Megan Awarded 30,000 Restricted Stock Units

Megan Rosengarten, a director at Neuronetics, Inc., was awarded 30,000 Restricted Stock Units (RSUs) on May 28, 2026. These RSUs vest on the earlier of May 28, 2027, or upon the Reporting Person's separation from service approved by the Board or a change in control of the Issuer, contingent upon continuous service. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The award has a transaction price of $0.00 per share. Following this transaction, Rosengarten holds 170,890 shares. The filing is Form 4, signed by Francis Brown as Attorney-in-Fact on May 29, 2026.